TP53 and neoplasm: Further studies are necessary to determine whether the overexpression of p53 protein in schirrous carcinoma is a primary phenomenon characterized by mutation of the p53 gene, or secondary to the interactions with other molecules embedded in the fibrous tumor stroma.